ENGLISH
繁體中文 ENGLISH

Investors-Financial Information

Material Information

Home

Investors

Financial Information

Material Information

Material Information Announcement

Click on the Market Observation Post System for public information, where you can search for significant information by year/month. Please enter the code 6782 for Visco Vision Inc. on the page linked.

SEQ_NO 4
Date of announcement 2026/05/26
Time of announcement 15:23:07
To which item it meets paragraph 21
Date of events 2026/05/26
Subject To announce the proposal of release the prohibition on newly appointed directors from participation in competitive business.
Statement
  1. Date of the shareholders meeting resolution:2026/05/26
  2. Name and title of the director with permission to engage in competitive conduct:
    director:Chung-I Li
    director:Ke-Yung Yu
    director:BenQ Materials Corp. representative:Pei-I Liu
    independent director:Chiu-Jui Wei
    independent director:Ying-Chou Yang
    independent director:Kuo-Kuang Chao
    independent director:Wei-Ting Lai
  3. Items of competitive conduct in which the director is permitted to engage:
    (1)Chung-I Li
    Corporate Chairperson Representative, Trend Young Vision Care Inc.
    Corporate Chairperson Representative and CSO, Crystalvue Medical Corp.
    (2)Ke-Yung Yu
    Corporate Director Representative, Trend Young Vision Care Inc.
    (3)BenQ Materials Corp.
    Director, Cenefom Corp.
    Director, LAGIS Enterprise Co., Ltd.
    Director, ConMed Biotech Inc.
    President, GeneJet Biotech Corp.
    President, WEB-PRO Corp.
    Engaged in the manufacturing of contact lenses.
    (4)BenQ Materials Corp. Representative: Pei-I Liu
    Vice President, BenQ Materials Corp.
    Corporate Director Representative, Cenefom Corp.
    Corporate Director Representative, WEB-PRO Corp.
    (5)Chiu-Jui Wei
    Senior Vice President, Compal Electronics, Inc.
    Corporate Director Representative, Compal Healthcare & Technology Ltd.
    Corporate Director Representative, General Life Biotechnology Co., Ltd.
    Corporate Director Representative, CDIB Partners Investment Holding Corp.
    Corporate Director Representative, Shengbao Precision Electronics(Taicang) Co., Ltd.
    Corporate Director Representative, Juteng Precision Machining(Jiangsu) Co., Ltd.
    Corporate Director Representative, Juteng Electronic Technology(Vietnam) Co., Ltd.
    Corporate Director Representative, Changbao Electronic Technology(Chongqing) Co., Ltd.
    Corporate Director Representative, Ray-Hono Technology(Hong Kong) Limited
    Corporate Director Representative, Hua Chi Venture Capital Co., Ltd.
    Corporate Director Representative, IIH Biomedical Venture Fund I Co., Ltd.
    Corporate Director Representative, Chenfeng Optronics Co., Ltd.
    Corporate Director Representative, ARCE Therapeutics, Inc.
    Director, Taiwan Genki Village Long-Term Care Juridical Person
    Independent Director, Continental Holdings Corp.
    (6)Ying-Chou Yang
    Independent Director, TSRC Corp.
    (7)Kuo-Kuang Chao
    Independent Director, Panram International Corp.
    Director, Advantech Foundation
    (8)Wei-Ting Lai
    Director of Ophthalmology, Min-Sheng General Hospital
    CMO, EyePlus
    President, EyePlus Co., Ltd.
  4. Period of permission to engage in the competitive conduct:2026/05/26~2029/05/25
  5. Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):Under Article 209 of the Company Act, the resolution is approved by the Company's Annual General Shareholders' Meeting on 2026/05/26.
  6. If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors(if it is not the operator of a Mainland-area enterprise, please enter “N/A” below):independent director:Chiu-Jui Wei
  7. Company name of the mainland China area enterprise and the director's position in the enterprise:
    Corporate Director Representative, Shengbao Precision Electron (Taicang) Limited Company
    Corporate Director Representative, Jubao Precision Processing (Jiangsu) Limited Company
    Corporate Director Representative, Changbao Electronic Technology (Chongqing) Co., Ltd
  8. Address of the mainland China area enterprise:
    Corporate Director Representative, Shengbao Precision Electron (Taicang) Limited Company:No. 40, Yueyang Road, Taiwan-funded Science and Technology Innovation Industrial Park, Shaxi Town, Taicang City, Jiangsu Province
    Corporate Director Representative, Jubao Precision Processing (Jiangsu) Limited Company:No.18 Jubao Road, Jurong City, Zhenjiang City, Jiangsu Province
    Corporate Director Representative, Changbao Electronic Technology (Chongqing) Co., Ltd:No. 326, Yixin Avenue, Youting Town, Dazu District, Chongqing
  9. Operations of the mainland China area enterprise:
    Corporate Director Representative, Shengbao Precision Electron (Taicang) Limited Company:Research and Developement、Production and Sales of new type Electronic Component
    Corporate Director Representative, Jubao Precision Processing (Jiangsu) Limited Company:Production of new alloy materials (magnesium/aluminum alloy) and related products (precision machining)
    Corporate Director Representative, Changbao Electronic Technology (Chongqing) Co., Ltd:Electronic product manufacturing
  10. Impact on the company's finance and business:N/A
  11. If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:N/A
  12. Any other matters that need to be specified:N/A
Go Back